id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S15251 R62707 |
Dudukina (Controls exposed to LTG) (Mixed indications), 2023 | Low birth weight (birth weight < 2500 g) | 3 months (or more) before pregnancy or during pregnancy | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: Yes |
0.86 [0.70;1.05] excluded (control group) |
147/2,414 366/7,241 | 513 | 2,414 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15252 R62728 |
Dudukina (Controls unexposed, NOS) (Mixed indications), 2023 | Low birth weight (birth weight < 2500 g) | 3 months (or more) before pregnancy or during pregnancy excluded | population based cohort retrospective | unexposed (general population or NOS) | Adjustment: Yes |
1.04 [0.89;1.23] excluded (exposition period) |
147/2,414 121,039/3,009,100 | 121,186 | 2,414 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S10100 R36795 |
Coste (Controls exposed to Lamotrigine, sick) (Mixed indications), 2020 | Weight at birth <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | exposed to other treatment, sick excluded | Adjustment: No |
1.20 [0.94;1.52] C excluded (control group) |
118/1,627 179/2,916 | 297 | 1,627 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8541 R28339 |
Coste (Controls unexposed, NOS) (Mixed indications), 2020 | Weight at birth <2500 g | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed (general population or NOS) | Adjustment: No | 1.38 [1.15;1.67] C | 118/1,627 91,455/1,710,441 | 91,573 | 1,627 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8537 R28307 |
Kilic (Controls exposed to Lamotrigine, sick) (Mixed indications), 2014 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | population based cohort retrospective | exposed to other treatment, sick excluded | Adjustment: No |
3.14 [0.68;14.55] C excluded (control group) |
2/13 48/876 | 50 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8538 R28310 |
Kilic (Controls unexposed NOS) (Mixed indications), 2014 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed (general population or NOS) excluded | Adjustment: No |
5.03 [1.12;22.70] C excluded (control group) |
2/13 23,503/673,844 | 23,505 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S8539 R28313 |
Kilic (Controls unexposed, sick) (Mixed indications), 2014 | Low birth weight (< 2500 g) | during pregnancy (anytime or not specified) | population based cohort retrospective | unexposed, sick | Adjustment: No Controls: epilepsy indication | 3.67 [0.81;16.65] C | 2/13 249/5,275 | 251 | 13 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 2 studies | 1.67 [0.79;3.54] | 91,824 | 1,640 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
1: Controls unexposed, NOS) (Mixed indications; 2: Controls unexposed, sick) (Mixed indications;
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 8537, 8538, 10100, 15251